Pharmacia and Upjohn Company LLC (storage of APIs, manufacturing, primary packaging, testing at release, batch release, secondary packaging, labeling)

The drug is prescribed for the treatment of metastatic colorectal cancer, metastatic breast cancer, non-small cell lung cancer, renal cell carcinoma, epithelial cancer of the ovaries and fallopian tubes, primary peritoneal cancer, as well as cervical cancer.

Dosage form: concentrate for infusion solution

ATC: L01FG01